Genetic and cellular alterations in B-cell lymphoma – Mechanisms of resistance
Brigitte Sola
Primary B-cell lymphoma and Hodgkin lymphoma
Functional effects of XPO1 mutations (in collaboration with Luca Grumolato, UNIROUEN, INSERM U982, IRIB, Rouen and Fabrice Jardin , INSERM U1245, centre Henri Becquerel, Rouen.
Multiple myeloma
Control of the glucidic metabolism by cyclin D1 in multiple myeloma cells (in collaboration with Olivier Hérault (LNox, CNRS UMR7292, University François Rabelais, Tours) and Olivier Coqueret (ICO Paul Papain, INSERM, Université d'Angers).ROSE project. Inducing a redox stress in myeloma cells to overcome bortezomib resistance (in collaboration with Gaël Roué, Vall d'Hebron Hospital, Barcelona, Spain).
Mantle cell lymphoma and multiple myeloma
Targeting proteaphagy to overcome bortezomib resistance in mantle celllymphoma and multiple myeloma (coll. Manuel S Rodriguez, ITAV,
Toulouse).
ITAV
UbiCARE team
UbiCODE project
Last update : March 12, 2020
Université de Caen Normandie
équipe MICAH
CHU niveau 3 | 5 avenue de la Côte de Nacre | 14032 Caen Cedex 5 | France
équipe MICAH
CHU niveau 3 | 5 avenue de la Côte de Nacre | 14032 Caen Cedex 5 | France
